Aging, Alzheimer's Disease, Biomarker, Neuroimaging

Journal Club & Current Status of Research on Soluble TREM2 in AD (January 21, 2022)
Posted onJan 21,2022


1.     Coomans, E. M., Tomassen, J., Ossenkoppele, R., Golla, S. S., den Hollander, M., Collij, L. E., ... & den Braber, A. (2022). Genetically identical twins show comparable tau PET load and spatial distribution. Brain.


Reporter: Anqi Li


2.     Dujardin S, Commins C, Lathuiliere A, Beerepoot P, Fernandes AR, Kamath TV, De Los Santos MB, Klickstein N, Corjuc DL, Corjuc BT, Dooley PM, Viode A, Oakley DH, Moore BD, Mullin K, Jean-Gilles D, Clark R, Atchison K, Moore R, Chibnik LB, Tanzi RE, Frosch MP, Serrano-Pozo A, Elwood F, Steen JA, Kennedy ME, Hyman BT. Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease. Nat Med. 2020 Aug;26(8):1256-1263. doi: 10.1038/s41591-020-0938-9. Epub 2020 Jun 22. Erratum in: Nat Med. 2021 Feb;27(2):356. PMID: 32572268; PMCID: PMC7603860.


Reporter: Jing Du


3.     An Overview of Soluble TREM2 in Alzheimer’s Disease


Reporter: Guoyu Lan


     Site: 807